145 related articles for article (PubMed ID: 14615103)
1. Complement dysregulation in haemolytic uraemic syndrome.
Bonnardeaux A; Pichette V
Lancet; 2003 Nov; 362(9395):1514-5. PubMed ID: 14615103
[No Abstract] [Full Text] [Related]
2. Familial haemolytic uraemic syndrome and an MCP mutation.
Noris M; Brioschi S; Caprioli J; Todeschini M; Bresin E; Porrati F; Gamba S; Remuzzi G;
Lancet; 2003 Nov; 362(9395):1542-7. PubMed ID: 14615110
[TBL] [Abstract][Full Text] [Related]
3. Complement factor H and the haemolytic uraemic syndrome.
Taylor CM
Lancet; 2001 Oct; 358(9289):1200-2. PubMed ID: 11675053
[No Abstract] [Full Text] [Related]
4. Genetic abnormalities of complement regulators in hemolytic uremic syndrome: how do they affect patient management?
Noris M; Remuzzi G
Nat Clin Pract Nephrol; 2005 Nov; 1(1):2-3. PubMed ID: 16932353
[No Abstract] [Full Text] [Related]
5. Do complement factor H 402Y and C7 M allotypes predispose to (typical) haemolytic uraemic syndrome?
Poolpol K; Gadner B; Neururer S; Mellmann A; Karch H; Orth D; Würzner R
Int J Immunogenet; 2011 Oct; 38(5):383-7. PubMed ID: 21649859
[TBL] [Abstract][Full Text] [Related]
6. [Complement regulatory proteins].
Miyagawa S
Nihon Rinsho; 2005 Apr; 63 Suppl 4():274-8. PubMed ID: 15861668
[No Abstract] [Full Text] [Related]
7. The regulation of the complement system: insights from genetically-engineered mice.
Turnberg D; Botto M
Mol Immunol; 2003 Sep; 40(2-4):145-53. PubMed ID: 12914820
[TBL] [Abstract][Full Text] [Related]
8. Atypical haemolytic uraemic syndrome.
Kavanagh D; Goodship TH; Richards A
Br Med Bull; 2006; 77-78():5-22. PubMed ID: 16968692
[TBL] [Abstract][Full Text] [Related]
9. The decay accelerating factor mutation I197V found in hemolytic uraemic syndrome does not impair complement regulation.
Kavanagh D; Burgess R; Spitzer D; Richards A; Diaz-Torres ML; Goodship JA; Hourcade DE; Atkinson JP; Goodship TH
Mol Immunol; 2007 May; 44(12):3162-7. PubMed ID: 17368771
[TBL] [Abstract][Full Text] [Related]
10. Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome.
Maga TK; Nishimura CJ; Weaver AE; Frees KL; Smith RJ
Hum Mutat; 2010 Jun; 31(6):E1445-60. PubMed ID: 20513133
[TBL] [Abstract][Full Text] [Related]
11. Atypical haemolytic uraemic syndrome and mutations in complement regulator genes.
Dragon-Durey MA; Frémeaux-Bacchi V
Springer Semin Immunopathol; 2005 Nov; 27(3):359-74. PubMed ID: 16189652
[TBL] [Abstract][Full Text] [Related]
12. Genetic disorders in complement (regulating) genes in patients with atypical haemolytic uraemic syndrome (aHUS).
Westra D; Volokhina E; van der Heijden E; Vos A; Huigen M; Jansen J; van Kaauwen E; van der Velden T; van de Kar N; van den Heuvel L
Nephrol Dial Transplant; 2010 Jul; 25(7):2195-202. PubMed ID: 20106822
[TBL] [Abstract][Full Text] [Related]
13. Mutations in CD46, a complement regulatory protein, predispose to atypical HUS.
Goodship TH; Liszewski MK; Kemp EJ; Richards A; Atkinson JP
Trends Mol Med; 2004 May; 10(5):226-31. PubMed ID: 15121049
[TBL] [Abstract][Full Text] [Related]
14. The hemolytic uremic syndromes.
Caprioli J; Peng L; Remuzzi G
Curr Opin Crit Care; 2005 Oct; 11(5):487-92. PubMed ID: 16175037
[TBL] [Abstract][Full Text] [Related]
15. Targeting complement C5 in atypical hemolytic uremic syndrome.
Salant DJ
J Am Soc Nephrol; 2011 Jan; 22(1):7-9. PubMed ID: 21127140
[No Abstract] [Full Text] [Related]
16. The development of atypical haemolytic-uraemic syndrome is influenced by susceptibility factors in factor H and membrane cofactor protein: evidence from two independent cohorts.
Fremeaux-Bacchi V; Kemp EJ; Goodship JA; Dragon-Durey MA; Strain L; Loirat C; Deng HW; Goodship TH
J Med Genet; 2005 Nov; 42(11):852-6. PubMed ID: 15784724
[TBL] [Abstract][Full Text] [Related]
17. [Atypical hemolytic-uremic syndrome related to abnormalities within the complement system].
Frémeaux-Bacchi V; Fakhouri F; Roumenina L; Dragon-Durey MA; Loirat C
Rev Med Interne; 2011 Apr; 32(4):232-40. PubMed ID: 21376430
[TBL] [Abstract][Full Text] [Related]
18. Complement factor h gene abnormalities in haemolytic uraemic syndrome: from point mutations to hybrid gene.
Noris M; Remuzzi G
PLoS Med; 2006 Oct; 3(10):e432. PubMed ID: 17076562
[TBL] [Abstract][Full Text] [Related]
19. Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome.
Buddles MR; Donne RL; Richards A; Goodship J; Goodship TH
Am J Hum Genet; 2000 May; 66(5):1721-2. PubMed ID: 10762557
[No Abstract] [Full Text] [Related]
20. Atypical haemolytic-uraemic syndrome due to heterozygous mutations of CFH/CFHR1-3 and complement factor H 479.
Chaudhary P; Hepgur M; Sarkissian S; Smith RJ; Weitz IC
Blood Transfus; 2014 Jan; 12(1):111-3. PubMed ID: 24333077
[No Abstract] [Full Text] [Related]
[Next] [New Search]
